Responses
Scientific Abstracts
Publication Only
Scleroderma, myositis and related syndromes
AB0728 Comparative results of long-term (for 36 months) use of rituximab and immunosuppressants in patients with systemic scleroderma with interstitial lung disease in real clinical practice
Compose a Response to This Article
Other responses
No responses have been published for this article.